If you are not happy with the results below please do another search
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a […]
It’s like buying 10 reports in one. This volume provides readers with in vitro diagnostic market sizing and forecasting in every area of the IVD industry. Published August 2023, the 16th edition of Kalorama’s The Worldwide Market for In Vitro Diagnostic Tests is a 1600+ page report based on vendor reporting, interviews, vendor activities, and more on a global scale. This dynamic market is projected to grow over the next five years, and this resource from Kalorama describes all of the ways that will happen, which areas are hot and cold, and which companies stand to benefit.
SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing. Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing. This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets […]
One of the most explored applications of molecular diagnostics is oncology, a segment with sales exceeding $6 billion in 2023, according to new data published in Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028, now on sale by leading medical and diagnostic market research firm Kalorama Information. In the report, the oncology segment is […]
The global market for LIS is forecast to increase at a high single-digit compound annual growth rate (CAGR) between 2022 and 2027, reveals leading medical market research publisher Kalorama Information in the new report World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027. Advances in healthcare will function as […]
The RNA sequencing market continues to offer potent tools with the potential to usher in significant transformations in healthcare in the foreseeable future. Over the past decade, there has been a remarkable surge in product launches, novel applications, and a rush of end-user labs eager to become major competitors in this $2.6 billion industry, according […]
COVID-19 hospitalizations in the U.S. have spiked in recent weeks amidst the advent of yet another new variant and the impending arrival of updated booster shots for a fall vaccination campaign. This late summer spike in infections comes after months of declines in COVID-related hospitalizations and deaths. The spike is poised to impact the in […]
In vitro diagnostic (IVD) testing is truly global as it has impacted every country in the world due to COVID-19 and it will continue to play an ever-increasing role in the practice of medicine. Social and economic events in selected countries will continue to influence the IVD market, but overall the IVD market plays an […]
In vitro diagnostics (IVDs) remain dynamic. The IVD market is a high R&D spend industry with constant innovations and routine interest from venture capital firms in diagnostic products. Nevertheless, the past few years have been very disruptive for IVDs. However, the resilient IVD industry has weathered the pandemic and is forging ahead with new technologies […]
Point of care IVD sales reached 45 billion dollars in 2022. This includes instruments – permanent and disposable, and associated reagents and supplies. Kalorama Information’s latest report details this: https://kaloramainformation.com/product/the-worldwide-market-for-point-of-care-poc-diagnostic-tests-10th-edition/ Point of care covers a variety of tests – some performed in a lab, some in a doctor’s office, some in a patient’s home […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
